July 3 (Reuters) - Granules India Ltd:
* GRANULES INDIA LTD SAYS ISSUES VOLUNTARY NATIONWIDE RECALL OF METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS USP, 750 MG
* GRANULES INDIA LTD SAYS GRANULES PHARMACEUTICALS, INC. HAS NOT RECEIVED ANY REPORTS OF ADVERSE EVENTS
* GRANULES INDIA LTD SAYS TEST RESULTS SHOWED NDMA LEVELS ABOVE FDA ACCEPTABLE LIMIT IN ONE OUT OF TWELVE BATCHES DISTRIBUTED TO US MARKET Source text for Eikon: Further company coverage:
Our Standards: The Thomson Reuters Trust Principles.